期刊文献+

MMP-2和TIMP-2在甲状腺癌中的表达及其意义 被引量:3

Expression of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinase-2 in thyroid carcinoma
下载PDF
导出
摘要 目的:探讨金属基质蛋白酶-2(MMP-2)和金属基质蛋白酶组织抑制剂-2(TIMP-2)在甲状腺良恶性肿瘤中的表达情况,分析MMP-2和TIMP-2与甲状腺癌的相关性。方法:采用逆转录酶-聚合酶链反应检测32例甲状腺癌、30例甲状腺良性肿瘤及18例癌旁组织MMP-2和TIMP-2mRNA的表达。结果:在甲状腺癌、甲状腺良性肿瘤和癌旁组织中MMP-2的表达率分别为78.1%(25/32)、20%(6/30)、16.7%(3/18),TIMP-2的表达率为65.6%(21/32)、26.7%(8/30)、11.1%(2/18),MMP-2的表达率在TNM分期Ⅲ+Ⅳ及淋巴结转移的标本中要高于TNM分期Ⅰ+Ⅱ及无淋巴结转移的标本,但TIMP-2的表达在这两类中无差别。在甲状腺癌组织中MMP-2和TIMP-2的表达呈正相关。Logistic回归分析结果显示:MMP-2与甲状腺癌关系密切,TIMP-2与甲状腺癌无相关性。结论:MMP-2和TIMP-2在甲状腺癌中表达明显提高,两者的表达呈正相关。MMP-2与甲状腺癌的关系更为密切,其表达上调往往提示甲状腺癌的转移和侵袭。 Objective: To study the expression of matrix metalloproteinase(MMP)-2 and tissue inhibitor of metalloproteinase (TIMP)-2 in thyroid carcinoma, and analysis the correlation between MMP-2,TIMP-2 and thyroid carcinoma. Methods :The expression of MMP-2 and TIMP-2 mRNA of 32 cases of carcinoma, 30 cases of adenoma and 18 cases of paraneoplastic tissue was detected by reverse transcriptasepolymerase chain reaction (RT-PCR). Results :The expression rate of MMP-2 in carcinoma, adenoma and paraneoplastic tissue was 78.1%(25/32), 20%(6/30), 16.7%(3/18) respectively, and TIMP-2 was 65.6%(21/ 32), 26.7%(8/30), 11.1 (2/18) respectively. There was a statistically significant higher expression of MMP-2 in TNM Ⅲ+Ⅳ and lymph node metastasis than TNM in Ⅰ + Ⅱ and no lymph node metastasis samples,but the expression of TIMP-2 had no statistically significant in the two gropes. There was a statistically significant positive correlation between expression of MMP-2 and TIMP-2.Logistic regression analysis displayed that there was a intimate relation between MMP-2 and thyroid carcinoma, and TIMP-2 had not. Conclusion: The mRNA expression of MMP-2 and TIMP-2 up-regulates in thyroid carcinoma, and has a positive relation. MMP-2 had a more intimate relation with thyroid carcinoma than TIMP-2 and Up-regulations of MMP-2 mRNA expression often indicates the metastasis and invasions of thyroid carcinoma.
出处 《天津医科大学学报》 2007年第4期552-555,共4页 Journal of Tianjin Medical University
关键词 甲状腺癌 金属基质蛋白酶-2 金属基质蛋白酶组织抑制剂-2 Thyroid carcinoma Matrix metalloproteinase-2 Tissue inhibitor of metalloproteinase-2
  • 相关文献

参考文献6

  • 1Nabeshima K, Inoue T, Shimao Y, et al. Matrix metalloproteinases in tumor invasion: role for cell migration[J]. Pathol Int, 2002, 52(4):255.
  • 2hoh Y, ho N, Nagase H, et al. Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1 -MMP [J]. Mol Biol Cell, 2006,17( 12):5390.
  • 3Takahashi E, Tateyama H, Akatsu H, et al. Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors[J]. Hum Pathol, 2003, 34( 12): 1253.
  • 4Bernard T, Jacques B , Wang C, et al.The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis [J]. Breast Cancer Res ,2006, 8 (3): 28.
  • 5Cho Mar K, Eimoto T, Tateyama H, et al. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions[J]. Histopathology, 2006, 48(3 ): 286.
  • 6Stephane H, Blanche S, Pieter V, et al. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart[J].Circulation, 2005,112(8): 1137.

同被引文献49

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部